The Effect of RNA Interference Suppressing the Expression of AKT2 on Sensitivity of Human Pancreatic Cancer Cell Line Xenograft in Nude Mice to Gemcitabine
10.3870/j.issn.1672-0741.2010.01.023
- VernacularTitle:RNA干扰AKT2影响人胰腺癌细胞株裸鼠移植瘤对吉西他滨的敏感性
- Author:
Tao PENG
;
Feng ZHOU
;
Peng YANG
;
Chunyou WANG
- Publication Type:Journal Article
- Keywords:
AKT2;
pancreatic cancer;
gemcitabine
- From:
Acta Medicinae Universitatis Scientiae et Technologiae Huazhong
2010;39(1):94-97
- CountryChina
- Language:Chinese
-
Abstract:
Objective To study the effect of RNA interference suppressing the expression of AKT2 on sensitivity of human pancreatic cancer cell line xenograft in nude mice to gemcitabine.Methods The human pancreatic cancer cell implanted tumor mode1 in the nude mice was established.By abdominal cavity administration and intratumoral injection,the mice bearing tumor were treated with gemcitabine in combination with vector of pAKT2-siRNA.Tumor growth of tumor tissues was observed,the AKT2 mRNA and protein expression levels in tumor tissues detected by RT-PCR and immunohistochemistry respectively,and tumor apoptosis measured by Tdt-mediated dUTP nick end labeling(TUNEL).Results In chemotherapy+AKT2-siRNA group the expression of AKT2 mRNA and protein was significantly lower than in control group,chemotherapy group and chemotherapy+blank plasmid group.The tumor weight and tumor volume in chemotherapy+AKT2-siRNA group were significantly reduced as compared with those in other three groups.The inhibition rate and apoptosis rate in chemotherapy+AKT2-siRNA group were significantly higher than those in other three groups.Conclusion Sensitivity of human pancreatic cancer cell line to gemcitabine could be significantly improved by RNA interference suppressing the expression of AKT2.
